Substance Use and Sex Index version 2 (SUSI‐2): Validation of a brief questionnaire for the measurement of behaviours associated with transmission of blood borne viruses and sexually transmitted infections

Documenti analoghi

• Commentary on Young et al .: Clinical guidance is required for stimulant co‐prescription with opioid agonist therapy
  di: Nadine Ezard, et al.
  Pubblicazione: (2025)
• Trends in gamma‐hydroxybutyrate use, harms and treatment in Australia, 2013 to 2024
  di: Amy Peacock, et al.
  Pubblicazione: (2026)
• Emergency department presentations, hospitalisations and police seizure data related to gamma‐hydroxybutyrate (GHB) in New South Wales, Australia, from 2015 to 2024
  di: Krista J. Siefried, et al.
  Pubblicazione: (2025)
• Exploring the Utility and Appropriateness of Dose Thresholds for Issuing of Public Drug Alerts on High‐Dose MDMA : A Qualitative Study
  di: Jack Freestone, et al.
  Pubblicazione: (2026)
• Psychometric evaluation of a trans‐addiction craving questionnaire: The Craving Assessment Scale for Behavioral Addictions and Substance‐use Disorders (CASBAS)
  di: Stephanie Antons, et al.
  Pubblicazione: (2025)